IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Avalo Therapeutics Inc

CUSIP: 05338F307 | 1 institutional holders

Quarters

Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Seven Fleet Capital Management LP360,064
1.7% of portfolio›$5.4M
StyleTurnoverLocationFiled
Seven Fleet Capital Management LP
360,064$5.4M1.7%GrowthVery HighMountain View, CA2026-06-04